Communiqués Ikena Oncology, Inc.

Actions

IKNA

US45175G1085

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 11/06/2024			Varia. 5j.	Varia. 1 janv.
1,81 ^USD	+2,26 %		+4,02 %	-8,12 %

29/05	IKENA ONCOLOGY, INC. : HC Wainwright toujours à l'achat	ZM
29/05	IKENA ONCOLOGY, INC. : Wedbush neutre sur le dossier	ZM

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

UPDATE – Ikena Oncology Announces Strategic Update	28/05	GL
Ikena Oncology Announces Strategic Update	28/05	GL
Ikena Oncology Announces Strategic Update	28/05	AQ
Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update	13/05	GL
Ikena Oncology : Corporate Presentation - April 2024	16/04	PU
Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum	10/04	GL
Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum	10/04	AQ
Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results	12/03	GL
Ikena Oncology to Participate in TD Cowen 44th Annual Health Care Conference	27/02	GL
Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer	21/02	GL
Ikena Oncology Outlines Key Priorities and Provides Corporate Updates	18/01	GL
Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results	09/11	GL
Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results	09/11	AQ
Ikena Oncology to Present at Multiple November 2023 Investor Conferences	07/11	GL
Ikena Oncology to Present at Multiple November 2023 Investor Conferences	07/11	AQ
Ikena Oncology : Corporate Presentation - Fall 2023	27/10/23	PU
Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Ikena Oncology Inc. (NASDAQ: IKNA)	02/10/23	PR
Ikena Oncology to Participate in September 2023 Investor Conferences	05/09/23	GL
Ikena Oncology : Corporate Presentation - Summer 2023	22/08/23	PU
Ikena Oncology Reports Second Quarter 2023 Financial Results and Corporate Update	10/08/23	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Ikena Oncology, Inc.

Actions

IKNA

US45175G1085

Communiqués

Filtres